Plaintiffs file reply in support of class certification in US Xyrem pay-for-delay suit
MLex Summary: Plaintiffs accusing Jazz Pharmaceuticals, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Par Pharmaceuticals and Lupin Pharmaceuticals of conspiring to delay a generic entry of Xyrem file a reply in support of class certification....To view the full article, register now.
Already a subscriber? Click here to view full article